🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Most of patients with autoimmune encephalitis are left with permanent cogni...
Status
Completed
Location
The First Affiliated Hospital, Zhejiang University
Start Date
2017-04-07
Trial ID
NCT03530462
Treatments Being Tested
The purpose of this study is to determine whether rituximab is effective in...
Status
Completed
Location
Cochin Hospital
Start Date
2013-04-09
Trial ID
NCT01748084
Treatments Being Tested
Idiopathic inflammatory myopathies (IIM) are a group of autoimmune conditio...
Status
Recruiting
Location
Singapore General Hospital
Start Date
2024-12-26
Trial ID
NCT07775235
Treatments Being Tested
Previously untreated CD20 positive diffuse large B-cell lymphoma (DLBCL) re...
Status
Completed
Location
Southampton University Hospitals NHS Tust
Start Date
2017-06-02
Trial ID
NCT03571308
Treatments Being Tested
The purpose of this trial is to compare the efficacy and safety of Inotuzum...
Status
Completed
Location
Stoke Mandeville Hospital (including Wycombe Hospital)
Start Date
2013-10
Trial ID
NCT01679119
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of the current t...
Status
Unknown
Location
The Second Xiangya Hospital, Central South University
Start Date
2018-12-01
Trial ID
NCT03791827
Phase 2 Study of Abbreviated 3 Cycles of Rituximab plus CHOP (Cyclophospham...
Status
Unknown
Location
Multiple Locations
Start Date
2016-12-07
Trial ID
NCT03399747
Treatments Being Tested
Diffuse large B-cell lymphoma is the most prevalent subgroup within maligna...
Status
Completed
Location
Landeskrankenhaus Feldkirch
Start Date
2007-12
Trial ID
NCT00575406
Treatments Being Tested
Primary Objective: To evaluate the effect of caplacizumab on prevention of...
Status
Completed
Location
Investigational Site Number 3920009
Start Date
2019-10-21
Trial ID
NCT04074187
The purpose of this study is to clarify the impact of rituximab on clinical...
Status
Completed
Location
Chonbuk National University Hospital
Start Date
2011-08
Trial ID
NCT01448096
Treatments Being Tested